Search results
Results from the WOW.Com Content Network
The main discussion of these abbreviations in the context of drug prescriptions and other medical prescriptions is at List of abbreviations used in medical prescriptions. Some of these abbreviations are best not used, as marked and explained here.
LOC: loss of consciousness level of consciousness (e.g., "altered LOC from head trauma") LOF: leakage of fluid LOH: loss of heterozygosity: LOI: loss of imprinting LOL: little old lady (often LOL in NAD—see House of God) lymph-obligatory load: LOM: limitation of motion LOP: left occiput posterior (fetal position) LORTA
Pronunciation follows convention outside the medical field, in which acronyms are generally pronounced as if they were a word (JAMA, SIDS), initialisms are generally pronounced as individual letters (DNA, SSRI), and abbreviations generally use the expansion (soln. = "solution", sup. = "superior").
Infections of the central nervous system may also be associated with decreased LOC; for example, an altered LOC is the most common symptom of encephalitis. [14] Neoplasms within the intracranial cavity can also affect consciousness, [12] as can epilepsy and post-seizure states. [9] A decreased LOC can also result from a combination of factors. [12]
Second, medical roots generally go together according to language, i.e., Greek prefixes occur with Greek suffixes and Latin prefixes with Latin suffixes. Although international scientific vocabulary is not stringent about segregating combining forms of different languages, it is advisable when coining new words not to mix different lingual roots.
A range of loci is specified in a similar way. For example, the locus of gene OCA1 may be written "11q1.4-q2.1", meaning it is on the long arm of chromosome 11, somewhere in the range from sub-band 4 of region 1 to sub-band 1 of region 2. [citation needed]
The term "anticoagulant" accurately describes its function in vitro. However in vivo , it functions as a procoagulant . [ 5 ] The "lupus anticoagulant paradox" [ 6 ] may be explained by platelet activation as described above, as well as enhancement of activated protein C resistance and suppression of the anticoagulant activity of TFPI α.
This difference is likely due to the difference between "perfect use" and "typical use". Perfect use indicates complete adherence to medication schedules and guidelines. Typical use describes effectiveness in real-world conditions, where patients may not fully adhere to medication regimens.